Tehran University of Medical Sciences Frontiers in Dentistry 2676-296X 23 0 2026 06 02 5062 5062 EN Neha Rathod . Department of Periodontics, Saveetha dental college and hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India M. Jeevitha Department of Periodontics, Saveetha dental college and hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India Pradeep Yadalam . Department of Periodontics, Saveetha dental college and hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India Amir Raee 2. Dental Implant Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran 3. Department of Periodontics, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran Artak Heboyan 4. Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India 5․ Department of Prosthodontics, Faculty of Stomatology, Yerevan State Medical University after Mkhitar Heratsi, Yerevan, Armenia 6. Department of Prosthodontics, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran 2023 12 31 2024 07 06 Objectives: A common inflammatory condition affecting oral health is periodontitis, which can lead to tooth loss if not treated early, as it destroys the supporting structures of the teeth. Fusobacterium nucleatum is an orange-pigmented bacterium commonly referred to as "the bridging species" between early and late colonizers in the oral microbiota, and it is associated with the progression of periodontal disease. This study aimed to develop an effective and precise multi-epitope vaccine against F. nucleatum, as there is currently no approved vaccine for periodontal disease. Materials and Methods: This study employed a computational method to design a multiple epitope-based vaccine against F. nucleatum using an immunoinformatics reverse vaccinology approach. FadA, a novel adhesin unique to F. nucleatum, was a suitable peptide for vaccine development. B- and T-cell epitopes were identified and assessed to design a multi-epitope vaccine. The developed vaccine construct was analyzed for potency based on its allergenicity, antigenicity, solubility, and stability. Results: The vaccine structure was non-allergenic and exhibited high antigenicity, stability, and solubility. This vaccine may be a candidate for eradicating F. nucleatum, based on predictions of immunogenicity responses. Conclusion: The designed vaccine construct could generate an effective immune https://fid.tums.ac.ir/index.php/fid/article/view/5062 https://fid.tums.ac.ir/index.php/fid/article/download/5062/2217